Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 39017* | 2016 |
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study S Yusuf, S Hawken, S Ôunpuu, T Dans, A Avezum, F Lanas, M McQueen, ... The lancet 364 (9438), 937-952, 2004 | 15967 | 2004 |
Dabigatran versus warfarin in patients with atrial fibrillation SJ Connolly, MD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, A Parekh, ... New England journal of medicine 361 (12), 1139-1151, 2009 | 13432 | 2009 |
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … MH Forouzanfar, A Afshin, LT Alexander, HR Anderson, ZA Bhutta, ... The lancet 388 (10053), 1659-1724, 2016 | 11736* | 2016 |
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of … T Vos, C Allen, M Arora, RM Barber, ZA Bhutta, A Brown, A Carter, ... The lancet 388 (10053), 1545-1602, 2016 | 9082* | 2016 |
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of … GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1736-1788, 2018 | 5264 | 2018 |
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic … SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1789-1858, 2018 | 4966 | 2018 |
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global … H Wang, M Naghavi, C Allen, RM Barber, ZA Bhutta, A Carter, DC Casey, ... The lancet 388 (10053), 1459-1544, 2016 | 4648 | 2016 |
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 M Naghavi, AA Abajobir, C Abbafati, KM Abbas, F Abd-Allah, SF Abera, ... The lancet 390 (10100), 1151-1210, 2017 | 4226 | 2017 |
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study MJ O'donnell, D Xavier, L Liu, H Zhang, SL Chin, P Rao-Melacini, ... The Lancet 376 (9735), 112-123, 2010 | 4136 | 2010 |
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial POISE Study Group The Lancet 371 (9627), 1839-1847, 2008 | 2439 | 2008 |
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial SS Jolly, S Yusuf, J Cairns, K Niemelä, D Xavier, P Widimsky, A Budaj, ... The Lancet 377 (9775), 1409-1420, 2011 | 2374 | 2011 |
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 … HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1859-1922, 2018 | 1852 | 2018 |
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 1813 | 2019 |
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study MJ O'Donnell, SL Chin, S Rangarajan, D Xavier, L Liu, H Zhang, ... The lancet 388 (10046), 761-775, 2016 | 1795 | 2016 |
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 … SI Hay, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ... The Lancet 390 (10100), 1260-1344, 2017 | 1477 | 2017 |
Comparison of fondaparinux and enoxaparin in acute coronary syndromes Fifth Organization to Assess Strategies in Acute Ischemic Syndromes ... New England Journal of Medicine 354 (14), 1464-1476, 2006 | 1446 | 2006 |
Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 VL Feigin, AA Abajobir, KH Abate, F Abd-Allah, AM Abdulle, SF Abera, ... The Lancet Neurology 16 (11), 877-897, 2017 | 1279 | 2017 |
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke RL Sacco, HC Diener, S Yusuf, D Cotton, S Ôunpuu, WA Lawton, ... New England Journal of Medicine 359 (12), 1238-1251, 2008 | 1202 | 2008 |
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. S Yusuf, SR Mehta, S Chrolavicius, R Afzal, J Pogue, CB Granger, ... Jama 295 (13), 1519-1530, 2006 | 1140 | 2006 |